COMPOUNDS FOR MODULATION OF CHOLESTEROL TRANSPORT

Details for Australian Patent Application No. 2003288925 (hide)

Event Publications

1 April 2004 Complete Application Filed

Priority application(s): 60/417,083 08.10.02 US

3 June 2004 Application Open to Public Inspection

Published as AU-A-2003288925

22 September 2005 Change of Name(s) of Applicant(s), Section 104

Center for Blood Research, Inc.; Massachusetts Institute of Technology The name of the applicant has been changed to Massachusetts Institute of Technology; The CBR Institute for Biomedical Research, Inc.

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.